期刊
JOURNAL OF LIPID RESEARCH
卷 56, 期 7, 页码 1363-1369出版社
ELSEVIER
DOI: 10.1194/jlr.D059725
关键词
inflammation; lipoprotein; lipid transfer protein; systemic inflammatory response syndrome; sepsis; human; mouse; diagnostic tool; mass spectrometry; liquid chromatography tandem mass spectrometry
资金
- INSERM (Institut National de la Sante Et de la Recherche Medicale)
- Regional Council of Bourgogne
- European Regional Development Fund
- University of Bourgogne
- Fondation de France
- Oseo/Banque Publique d'Investissement
- French government [ANR-11-LABX-0021-01-Lip-STIC LabEx]
Quantitation of plasma lipopolysaccharides (LPSs) might be used to document Gram-negative bacterial infection. In the present work, LPS-derived 3-hydroxymyristate was extracted from plasma samples with an organic solvent, separated by reversed phase HPLC, and quantitated by MS/MS. This mass assay was combined with the limulus amebocyte lysate (LAL) bioassay to monitor neutralization of LPS activity in biological samples. The described HPLC/MS/MS method is a reliable, practical, accurate, and sensitive tool to quantitate LPS. The combination of the LAL and HPLC/MS/MS analyses provided new evidence for the intrinsic capacity of plasma lipoproteins and phospholipid transfer protein to neutralize the activity of LPS. In a subset of patients with systemic inflammatory response syndrome, with documented infection but with a negative plasma LAL test, significant amounts of LPS were measured by the HPLC/MS/MS method. Patients with the highest plasma LPS concentration were more severely ill. HPLC/MS/MS is a relevant method to quantitate endotoxin in a sample, to assess the efficacy of LPS neutralization, and to evaluate the proinflammatory potential of LPS in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据